Cyclerion Therapeutics In... (CYCN)
NASDAQ: CYCN
· Real-Time Price · USD
3.14
-0.16 (-4.85%)
At close: May 02, 2025, 3:56 PM
3.25
3.36%
After-hours: May 02, 2025, 04:00 PM EDT
-4.85% (1D)
| Bid | 3 |
| Market Cap | 8.52M |
| Revenue (ttm) | 2M |
| Net Income (ttm) | -3.06M |
| EPS (ttm) | -1.21 |
| PE Ratio (ttm) | -2.6 |
| Forward PE | -0.17 |
| Analyst | n/a |
| Ask | 3.45 |
| Volume | 14,635 |
| Avg. Volume (20D) | 556,906 |
| Open | 3.14 |
| Previous Close | 3.30 |
| Day's Range | 3.06 - 3.45 |
| 52-Week Range | 1.27 - 9.47 |
| Beta | 1.96 |
About CYCN
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes, as well as Alzheimer's dis...
Industry Biotechnology
Sector Healthcare
IPO Date Mar 18, 2019
Employees 1
Stock Exchange NASDAQ
Ticker Symbol CYCN
Website https://www.cyclerion.com
